Research Interests
Stroke Systems of Care, acute stroke care delivery, inpatient neurology quality assurance and quality improvement
Selected Grants
A Global,Phase 2,Randomized,Double-Blind,Placebo-Controlled,Response-Adaptive Dose-Ranging Study of BMS-986177,anOralFactorXIa Inhibitor,for the PreventionofNewIschemi Stroke or New Silent Brain Infarction in Patients ReceivingAspirin and clopidogre
Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2019 - 2021External Relationships
- MEE Vascular Neurology Legal Consulting
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.